CTLA4 and neoplasm: The fact that the percentage of ‘ips_ctla4_neg_pd1_neg’ is greater in the low-risk group than in the high-risk group suggests that patients in the low-risk group have a lesser expression of CTLA-4 and PD-1 immune checkpoint proteins in their tumor microenvironment.